Regulatory T-cell therapy in Crohn’s disease: challenges and advancesJennifer Clough(King's College London), Peter M. Irving(Guy's and St Thomas' NHS Foundation Trust)GutJanuary 24, 202010.1136/gutjnl-2019-319850Cited by 159SaveCiteExport RISWatch citationsRelated PapersUstekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial|The Lancet|2022|295Developing in vitro expanded CD45RA<sup>+</sup>regulatory T cells as an adoptive cell therapy for Crohn's disease|Gut|2015|194Sequencing of over 100,000 individuals identifies multiple genes and rare variants associated with Crohns disease susceptibility|medRxiv|2021|11